Cameroon vs Lao People's Democratic Republic: Previously treated cases tested for RR-/MDR-TB
Cameroon
100.0%
in 2024
Lao People's Democratic Republic
100.0%
in 2024
Cameroon rank
1st
Lao People's Democratic Republic rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Cameroon
- Lao People's Democratic Republic
How they compare
Cameroon currently reports 100.0% against 100.0% in Lao People's Democratic Republic, a difference of 0.0%.
The two have swapped places 2 times across 13 shared years of data; in 2012 it was Lao People's Democratic Republic ahead.
Cameroon ranks 1st and Lao People's Democratic Republic ranks 1st of 180 countries.
Across the 2 decades both report, Cameroon averaged higher in 1 and Lao People's Democratic Republic in 1.
Head to head by decade
| Decade | Cameroon | Lao People's Democratic Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 59.1% | 50.5% | 8.6% | Cameroon |
| 2020s | 97.2% | 100.0% | 2.8% | Lao People's Democratic Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Cameroon or Lao People's Democratic Republic?
- Cameroon, at 100.0% against 100.0% in Lao People's Democratic Republic as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Cameroon and Lao People's Democratic Republic?
- 0.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Lao People's Democratic Republic?
- 13 years are reported by both, from 2012 to 2024.
- How do Cameroon and Lao People's Democratic Republic rank globally for previously treated cases tested for rr-/mdr-tb?
- Cameroon ranks 1st and Lao People's Democratic Republic ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.